Pharmaceuticals

Johnson & Johnson (J&J) reported adjusted earnings and revenue on Tuesday that exceeded Wall Street’s expectations, leading the company to raise its full-year guidance. This comes after J&J completed its separation from consumer health spinoff Kenvue in August, marking the largest shake-up in the company’s history. After the split, J&J initially lowered its full-year sales…